Astellas Pharma Inc. (TYO:4503)
2,699.00
+21.00 (0.78%)
Nov 13, 2026, 3:30 PM JST
Astellas Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains ¥2,200 → ¥2,250 | Hold | Maintains | ¥2,200 → ¥2,250 | -16.64% | Nov 5, 2026 |
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains ¥2,700 → ¥2,900 | Buy | Maintains | ¥2,700 → ¥2,900 | +7.45% | Nov 5, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Sell Maintains ¥1,700 → ¥2,000 | Sell | Maintains | ¥1,700 → ¥2,000 | -25.90% | Sep 30, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Hold Maintains ¥2,440 | Hold | Maintains | ¥2,440 | -9.60% | Sep 14, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains ¥3,000 | Buy | Maintains | ¥3,000 | +11.15% | Aug 18, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains ¥2,300 → ¥2,500 | Hold | Maintains | ¥2,300 → ¥2,500 | -7.37% | Aug 17, 2026 |
| Citi | Citi | Hold Maintains ¥2,470 | Hold | Maintains | ¥2,470 | -8.48% | Aug 7, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains ¥3,000 → ¥3,100 | Buy | Maintains | ¥3,000 → ¥3,100 | +14.86% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.